Loading…
Eureka International Summer Course in Translational Medicine...
Tuesday July 7, 2026 09:15 - 10:15 CEST
Intellectual property (IP) is a critical component of innovation in translational medicine, providing the legal protection necessary to safeguard novel ideas and inventions. Often overlooked in scientific training, IP is essential not only for commercialization but also for ensuring that research can be successfully translated to benefit patients. This session will cover the basics of intellectual property, its significance in the translational medicine process, and why and when researchers should start considering IP. We will discuss how early IP considerations can significantly impact the success of translating research into practical applications. The session will also relate these principles and their practical application to our case study.
Learning Objectives:
  1. Understand the basics of intellectual property and its role in protecting innovation.
  2. Recognize the importance of intellectual property in translational medicine, beyond just commercialization.
  3. Apply intellectual property principles to the ongoing case study, illustrating their practical significance and timing consideration.
Speakers
avatar for Claudia Ogilvie

Claudia Ogilvie

Patent attorney, De Vries & Metman
Claudia Ogilvie is a senior patent attorney specialized in patent drafting, patent prosecution, and patent counselling in the biochemical and pharmaceutical field. Her technical expertise includes antibody and vaccine technology, (bio)pharmaceuticals, and diagnostic and prognostic... Read More →
Tuesday July 7, 2026 09:15 - 10:15 CEST
TBA

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link